![]() |
Friday, September 9, 2005
Technology Briefing
Seattle-based Teranode has raised $9.5 million in venture capital financing in a deal led by Cargill Ventures and Trident Capital. Existing investors -- Ignition Partners and WRF Capital -- also participated.
Teranode, which will use the funds for marketing and product development, makes software that helps scientists better design and automate laboratory experiments. Its products have been used by Pfizer, AsraZeneca and the Fred Hutchinson Cancer Research Center. It is led by Joe Duncan, a former executive at Critical Path, Oracle and the University of Washington's Cell Systems Initiative.
Gregory Weaver, chief financial officer of Nastech Pharmaceutical Co. Inc., has resigned, the Bothell biotechnology company says. It said Philip Ranker, vice president of finance, will serve as the interim chief financial officer. Bruce York will become interim chief accounting officer. He had served as senior director of accounting and corporate controller.
|
Stocks |

more
more
more

101 Elliott Ave. W.
Seattle, WA 98119
(206) 448-8000
Home Delivery: (206) 464-2121 or (800) 542-0820
seattlepi.com serves about 1.7 million unique visitors
and 30 million page views each month.
Send comments to newmedia@seattlepi.com
Send investigative tips to iteam@seattlepi.com
©1996-2008 Seattle Post-Intelligencer
Terms of Use/Privacy Policy
